Results of the Ordinary and Extraordinary Shareholders' Meetings of Solvac
15 Mai 2019 - 12:30PM
Results of the Ordinary and Extraordinary Shareholders' Meetings of
Solvac
Brussels, 15 May 2019 - The
Ordinary and Extraordinary Shareholders' General Meetings of Solvac
met on May 14, 2019 at the Square, Brussels Meeting Center, Mont
des Arts, 1000 Brussels.
All the resolutions of these Meetings were
adopted by the shareholders.
In particular, the Ordinary General Meeting
approved the payment of dividend per share at € 5.22 gross for the
fiscal year 2018, an increase of 4.0% compared to 2017. During this
meeting, the shareholders also approved:
- the re-election of Knight Guy de Selliers de Moranville and Mrs
Laure le Hardÿ de Beaulieu as independent Board Members and Knight
John Kraft de la Saulx as non-independent Member of the Board of
Directors for a period of four years, until in May 2023. Mrs
Mélodie de Pimodan was appointed Independent Board Member of the
Board of Directors for four years, replacing Aude Thibaut de
Maisières who decided not to seek a new term of Board Member,
- the term renewal of Deloitte Bedrijfsrevisoren/Réviseurs
d’Entreprises, Société Civile sous forme de SCRL, whose
headquarters are located at 1930 Zaventem, Gateway Building,
Luchthaven Brussel Nationaal 1 J, as External Auditor for the
company for a period of three years. The appointment of External
Auditor will end at the close of the General Shareholders’ Meeting
in May 2022.
The Extraordinary General Meeting approved the
changes in the by-laws in Article 10bis relating to the authorized
capital and in Article 10ter for acquisition of own shares.
Detailed resolutions, voting results and
presentations are available on the Solvac website at
https://www.solvac.be/fr/investisseurs/assemblees-generales/
Solvac is a public limited company under Belgian
law founded in 1983 and listed on Euronext Brussels under the ISIN
code BE0003545531 (SOLV). Its assets consist
exclusively of a stake of more than 30% in the capital of Solvay
SA. Its shares are exclusively nominative. They may be freely held
by natural persons or, subject to the approval of the Board of
Directors, by legal persons or assimilated, to the conditions set
out in its accreditation policy. At December 31, 2018, its market
capitalization was 2.4 billion €.
For additional information, please contact:
Solvac S.A.Champs Elysées street, 43B-1050
BrusselsTel. : +32/2/639 66 30Fax : +32/2/639 66 31Mail :
Investor.relations@solvac.be
- 2019 General Meetings Results
Solvac (EU:SOLV)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Solvac (EU:SOLV)
Historical Stock Chart
Von Jan 2024 bis Jan 2025